ADVAXIS, INC. : Other Events (form 8-K)

Item 8.01 Other Events.

On January 7, 2020, Advaxis, Inc. (the "Company") issued a press release announcing that the United States Food and Drug Administration has cleared the Investigational New Drug for the initiation of a Phase 1 clinical study of ADXS-504. The Company's press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference.

Item 9.01 Exhibits.



(d) Exhibits



Exhibit No.   Description
99.1            Press Release of Advaxis, Inc. dated January 7, 2020.

© Edgar Online, source Glimpses